Diagnostics News and Research

RSS

Heart Rhythm Society launches Boston Citywide Awareness Campaign

Massachusetts Governor Deval Patrick has proclaimed May to be Cardiac Arrhythmia Awareness Month, calling attention to the need for greater public awareness throughout the Commonwealth about two serious heart rhythm conditions, atrial fibrillation and sudden cardiac arrest. To support consumer education about these potentially life-threatening disease states, the Heart Rhythm Society (HRS) has launched a Boston Citywide Awareness Campaign to increase knowledge about symptoms, warning signs and available treatment options.

2 May 2012

Exact Sciences first quarter net loss increases to $10.6 million

Exact Sciences Corp. today announced its financial results for the quarter ended March 31, 2012.

2 May 2012

LifeCodexx completes PraenaTest clinical study on trisomy 21

LifeCodexx today announced the successful completion of the clinical validation study of its noninvasive test method for the detection of fetal trisomy 21 from maternal blood using Next Generation sequencing.

2 May 2012

Financial Times examines Cuban company selling larvicides for malaria control in Africa

Though "[m]ost international support credited with the recent decline in malaria in Africa has been channeled to providing bednets, diagnostics and drugs, a Cuban company called Labiofam is marketing bacterial larvicides in Africa to help fight the disease," the Financial Times reports.

30 Apr 2012

U.S. government is largest funder of global health R&D, report shows

"The U.S. government is the largest funder of global health research and development [R&D] in the world, spending $12.7 billion over the past 10 years," according to a report (.pdf) released on Friday by the Global Health Technologies Coalition (GHTC) and Policy Cures, United Press International reports.

30 Apr 2012

Trovagene completes PCR assay development for detection of K-RAS mutations

Trovagene, Inc., a developer of trans-renal molecular diagnostics, announced today that the Company has successfully completed the analytical development of digital PCR assays for the detection of the most prevalent K-RAS mutations, which are, according to recent estimates, observed in more than 90% of pancreatic cancers, and in 23% of all solid tumors.

30 Apr 2012

Children's bad behaviour may be due to mental disorders

When children behave badly, it's easy to blame their parents. Sometimes, however, such behavior may be due to a mental disorder.

30 Apr 2012

Hologic second quarter revenues increase 7.4% to $471.2 million

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced its results for the second fiscal quarter ended March 24, 2012.

From Hologic, Inc. 30 Apr 2012

Hologic enters definitive agreement to acquire Gen-Probe

Hologic, Inc. and Gen-Probe Incorporated today announced that their Boards of Directors have unanimously approved a definitive agreement under which Hologic will acquire all of the outstanding shares of Gen-Probe for $82.75 per share in cash, or a total enterprise value of approximately $3.7 billion.

From Hologic, Inc. 30 Apr 2012

Five U.S. federal agencies provide significant contributions each year to global health R&D

A new report that the United States government is the largest funder of global health research and development (R&D) in the world, investing $12.7 billion over the past 10 years in the creation of new vaccines, drugs, diagnostics, and other products for neglected diseases of the developing world. That funding, according to the report, helped lead to the development of more than half of the 45 new health products in the last decade that have been used to save lives around the world.

30 Apr 2012

InDex Pharmaceuticals granted U.S. patent for novel treatment of steroid-resistant inflammation

InDex Pharmaceuticals today announced that it has been granted a patent by the United States Patent and Trademark Office. The patent provides additional protection for the use of Kappaproct® and additional DNA-based immunomodulatory sequences (DIMS) for the treatment of steroid-resistant inflammatory diseases including inflammatory bowel disease, rheumatoid arthritis, psoriasis, asthma, emphysema and chronic obstructive pulmonary disease.

26 Apr 2012

PLUS Diagnostics, MDxHealth partner to co-promote ConfirmMDx for Prostate Cancer

MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, and PLUS Diagnostics today announced that they have entered into an agreement to co-promote MDxHealth's ConfirmMDx for Prostate Cancer test in the United States.

26 Apr 2012

NYU Langone expands MS Comprehensive Care Center

NYU Langone's Multiple Sclerosis (MS) Comprehensive Care Center recently opened the doors to a new clinical practice - the first to occupy NYU Langone Medical Center's new, nearly 300,000-square-foot Ambulatory Care Center located at 240 East 38th Street at Second Avenue in Manhattan.

26 Apr 2012

Lophius Biosciences completes prospective multicenter clinical validation study for T-Track CMV/EBV tests

Lophius Biosciences, a leading developer of novel T-cell based diagnostic testing systems, today announces the successful completion of a prospective multicenter clinical validation study for its T-Track CMV/EBV tests.

25 Apr 2012

Thermo Fisher Scientific first quarter revenues increase 14% to record $3.10 billion

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the first quarter ended March 31, 2012.

From Thermo Fisher Scientific Inc. 25 Apr 2012

Aggredyne closes $3 million Series A convertible preferred stock financing

Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.

23 Apr 2012

DSG's eCaseLink EDC chosen for Ariosa's Non-Invasive Chromosomal Examination of Trisomy study

Ariosa Diagnostics, a molecular diagnostics company focused on prenatal testing, has chosen to use DSG's eCaseLink EDC (electronic data capture) system for the NEXT (Non-Invasive Chromosomal Examination of Trisomy) study.

23 Apr 2012

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Abbott and St. Jude Medical today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

23 Apr 2012

Fun ways for women to get active with 100,000 Acts of Play Challenge

A new survey from the American Cancer Society finds women are 10 percent less likely than men to make time for physical activities they enjoy and that 40 percent of women said they would be more physically active in their free time if it felt less like work and more like play. As a result, the American Cancer Society Choose You movement is calling on women to help close this gap and to discover fun ways to get active with its 100,000 Acts of Play Challenge.

23 Apr 2012

Health Discovery launches MelApp for melanoma risk assessment

Health Discovery Corporation, the molecular diagnostics company that launched MelApp, the first SVM-based image analysis iPhone app for melanoma risk assessment is featured in this month's Men's Health Magazine.

21 Apr 2012

Diagnostics News and Research

Heart Rhythm Society launches Boston Citywide Awareness Campaign

Exact Sciences first quarter net loss increases to $10.6 million

LifeCodexx completes PraenaTest clinical study on trisomy 21

Financial Times examines Cuban company selling larvicides for malaria control in Africa

U.S. government is largest funder of global health R&D, report shows

Trovagene completes PCR assay development for detection of K-RAS mutations

Children's bad behaviour may be due to mental disorders

Hologic second quarter revenues increase 7.4% to $471.2 million

Hologic enters definitive agreement to acquire Gen-Probe

Five U.S. federal agencies provide significant contributions each year to global health R&D

InDex Pharmaceuticals granted U.S. patent for novel treatment of steroid-resistant inflammation

PLUS Diagnostics, MDxHealth partner to co-promote ConfirmMDx for Prostate Cancer

NYU Langone expands MS Comprehensive Care Center

Lophius Biosciences completes prospective multicenter clinical validation study for T-Track CMV/EBV tests

Thermo Fisher Scientific first quarter revenues increase 14% to record $3.10 billion

Aggredyne closes $3 million Series A convertible preferred stock financing

DSG's eCaseLink EDC chosen for Ariosa's Non-Invasive Chromosomal Examination of Trisomy study

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Fun ways for women to get active with 100,000 Acts of Play Challenge

Health Discovery launches MelApp for melanoma risk assessment

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News